
501 - 1000 funcionários
Fundada em 2014
🧬 Biotecnologia
💊 Farmacêutico
⚕️ Seguro de Saúde
Biotechnology • Pharmaceuticals • Healthcare Insurance
A Iovance Biotherapeutics, Inc. está revolucionando o tratamento do câncer ao aproveitar a capacidade do sistema imunológico humano de reconhecer e atacar células cancerígenas diversas em cada paciente. A empresa se concentra em imunoterapia baseada em células T, especificamente a terapia com Linfócitos T Infiltrantes de Tumor (TIL), que consiste em revigorar os TILs de um paciente para combater o câncer. A terapia TIL da Iovance está sendo investigada em ensaios clínicos para diversos tipos de câncer sólidos avançados. Além disso, a empresa está avançando em terapias TIL geneticamente modificadas e explorando aplicações potenciais da terapia PBL (linfócitos do sangue periférico) para cânceres hematológicos. Como líder em terapia celular, a Iovance possui um moderno Centro de Terapia Celular na Filadélfia para fabricar suas terapias utilizando GMP proprietária. A empresa está na vanguarda do desenvolvimento de tratamentos contra o câncer personalizados e específicos para cada paciente.
🕒 Abril 24
🗣️🇺🇸🇬🇧 Inglês obrigatório
Melhore suas chances de conseguir uma entrevista verificando sua pontuação de currículo antes de se candidatar.

501 - 1000 funcionários
Fundada em 2014
🧬 Biotecnologia
💊 Farmacêutico
⚕️ Seguro de Saúde
Biotechnology • Pharmaceuticals • Healthcare Insurance
A Iovance Biotherapeutics, Inc. está revolucionando o tratamento do câncer ao aproveitar a capacidade do sistema imunológico humano de reconhecer e atacar células cancerígenas diversas em cada paciente. A empresa se concentra em imunoterapia baseada em células T, especificamente a terapia com Linfócitos T Infiltrantes de Tumor (TIL), que consiste em revigorar os TILs de um paciente para combater o câncer. A terapia TIL da Iovance está sendo investigada em ensaios clínicos para diversos tipos de câncer sólidos avançados. Além disso, a empresa está avançando em terapias TIL geneticamente modificadas e explorando aplicações potenciais da terapia PBL (linfócitos do sangue periférico) para cânceres hematológicos. Como líder em terapia celular, a Iovance possui um moderno Centro de Terapia Celular na Filadélfia para fabricar suas terapias utilizando GMP proprietária. A empresa está na vanguarda do desenvolvimento de tratamentos contra o câncer personalizados e específicos para cada paciente.
• Partner with Policy and Payer Marketing on engagement strategy with external partners and formulary decision-makers primarily in national/regional health plans, CMS, integrated delivery networks (IDNs), ATCs, Large physician groups (LPGs) • Owns the development and execution of payer resources, reimbursement resources, end-to-end payer and channel marketing; provides resources to support the market access field team and pull through strategies • Build and drive the US value proposition story for AMTAGVI and pipeline therapies to include but not limited to impact of complete and partial responses on PROs, productivity and future treatment costs and pharmacoeconomic impact of evolving treatment patterns • Incorporate health economics, business analytics and competitive intelligence into the development of innovative strategies to gain, improve and defend public and private market access, specifically, pricing (and contracting) strategic planning within Market Access to create innovative proposals to meet public and private payer needs • Directs the strategy and maintenance of formulary submission packages, total cost of care US models and other economic modeling and healthcare resource use analyses • Support field-based cross-functional teams to provide pharmacoeconomic expertise in access engagements • Manages operations and ensures compliance of Iovance Pricing Committee, GTN implications review and update charter and plan agendas to drive development of Committee recommendations • Assess clinical and economic data gaps at key accounts and collaborate with internal stakeholders: Medical, Policy, Reimbursement HEOR, Payer Accounts, Marketing, Legal to provide insight into health economic value needs • Support Market Access Account team(s) with Payer and Formulary Decision Makers at key congresses, such as PCMA, AMCP, ASTCT as needed • Work cross functionally as a liaison with the brand teams to develop, implement, and communicate strategies and tactics to ensure alignment within the Market Access team on key cross-functional priorities • Partnering with Commercial Strategy on Market Readiness, trial design and endpoint considerations, FDAMA and value evidence creation and Go-to-Market approach • Assist on pipeline products and indications to generate key evidence and value proposition • Provide strategic support and clinical-economic content expertise in innovation and partnership opportunities • Operate at the highest level of compliance and professional standards demonstrated by embracing ethical decision-making practices and guidelines in all aspects of our organization • Acts as the subject matter expert for all health care economic policy • Must adhere to Iovance Biotherapeutics’ core values, policies, procedures, and business ethics. • Perform miscellaneous duties assigned
• Doctorate degree (PharmD, MD, DO or PhD) preferred, or equivalent combination of advanced degree and relevant experience • 12 + years background/experience in pharmacoeconomic, cost-effectiveness, HEOR and payer interactions • Cell therapy, Hematology/Oncology experience preferred • Proven ability to develop and maintain relationships with key decision-makers in the US healthcare/economics ecosystem • Experience in assessing and analyzing clinical and HEOR data gaps to provide relevant access solutions • Must be a strong team player and effectively interface with other internal departments including regional business units, marketing, sales, medical affairs, and clinical operations • Excellent communication and presentational skills • Ability to take initiative and work both independently and in a team environment multi-tasking, time management, and organizational skills with proficiency in Microsoft applications.
Candidatar-se🕒 Abril 23
Director of Pricing-Integration driving pricing strategy and analytics at ESAB. Leading global team in pricing automation challenges and performance tracking across multiple industries.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $196.818 - $229.576 / ano
⏰ Tempo Integral
🔴 Especialista
👔 Diretor
🦅 Patrocina Visto H1B
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Abril 23
Scientific Director overseeing oncology publications for pharmaceutical clients. Leading content development activities and managing scientific communications across therapeutic areas.
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Abril 23
Director of Health Economics & Outcomes Research at Tivity Health. Leading the generation of clinical and economic insights to support corporate strategy and product development.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $114.800 - $140.000 / ano
💰 Post-IPO Equity em 2013-10
⏰ Tempo Integral
🔴 Especialista
👔 Diretor
🦅 Patrocina Visto H1B
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Abril 23
Clinical Trials Site Director overseeing site performance and clinical trial execution. Leading teams and improving processes in a rapidly expanding clinical research network.
🇺🇸 Estados Unidos – Remoto (EUA)
💰 $2.900.000 Venture Round em 2022-05
⏰ Tempo Integral
🔴 Especialista
👔 Diretor
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Abril 23
Technical Director providing strategic and technical leadership across multiple projects at Nearform. Ensuring alignment with business goals while fostering innovation and excellence.
🗣️🇺🇸🇬🇧 Inglês obrigatório